Adult-type diffuse gliomas are the most common primary malignant brain tumors, and over 30% have a mutation in IDH1 or IDH2. This is a critical prognostic marker, associated with significantly longer overall and progression-free survival compared to IDH1/2-wildtype adult-type diffuse gliomas. This evidence concerns the gene IDH1 and brain neoplasm.